Effects of supraphysiologic doses of testosterone on mood and aggression in normal men: A randomized controlled trial

Archives of General Psychiatry

Volumn 57, Issue 2, 2000, Pages 133-140

  Pope Jr , Harrison G ^a,c   Kouri, Elena M ^a   Hudson, James I ^b  

^a HARVARD MEDICAL SCHOOL   (United States)

^b HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^c MCLEAN HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANABOLIC AGENT; ANDROGEN; PLACEBO; TESTOSTERONE CIPIONATE;

ADULT; AFFECTIVE NEUROSIS; AGGRESSION; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DEPRESSION; DOUBLE BLIND PROCEDURE; HUMAN; HUMAN EXPERIMENT; MALE; MANIA; NORMAL HUMAN; PROVOCATION TEST; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; WEIGHT LIFTING;

EID: 0343114275     PISSN: 0003990X     EISSN: None     Source Type: Journal    
DOI: 10.1001/archpsyc.57.2.133     Document Type: Article

References (57)

1. Pope HG Jr, Katz DL. Psychiatric effects of exogenous anabolic-androgenic steroids. In: Wolkowitz OM, Rothschild AJ, eds. Psychoneuroendocrinology for the Clinician. Washington, DC: American Psychiatric Press. In press.
2. Yesalis CE, Kennedy NJ, Kopstein AN, Bahrke MS. Anabolic-androgenic steroid use in the United States. JAMA. 1993;270:1217-1221.
3. Buckley WA, Yesalis CE, Friedl KE, Anderson W, Streit A, Wright J. Estimated prevalence of anabolic steroid use among male high school seniors. JAMA. 1988; 260:3441-3445.
4. Durant RH, Rickert VI, Ashworth CS, Newman C, Slavens G. Use of multiple drugs among adolescents who use anabolic steroids. N Engl J Med. 1993;328:922-926.
5. Pope HG Jr, Katz DL. Affective and psychotic symptoms associated with anabolic steroid use. Am J Psychiatry. 1988;145:487-490.
6. Pope HG Jr, Katz DL. Psychiatric and medical effects of anabolic-androgenic steroid use. Arch Gen Psychiatry. 1994;51:375-382.
7. Parrott AC, Choi PYL, Davies M. Anabolic steroid use by amateur athletes: effects upon psychological mood states. J Sports Med Phys Fitness. 1994;34:292-298.
8. Choi PYL, Parrott AC, Cowan D. High-dose anabolic steroids in strength athletes: effects upon hostility and aggression. Human Psychopharmacol. 1990;5:349-356.
9. Lefavi RG, Reeve TG, Newland MC. Relationship between anabolic steroid use and selected psychological parameters in male bodybuilders. J Sports Behav. 1990;13:157-166.
10. Perry PJ, Yates WR, Andersen KH. Psychiatric symptoms associated with anabolic steroids: a controlled, retrospective study. Ann Clin Psychiatry. 1990;2:11-17.
11. Moss HB, Panzak GL, Tarter RE. Personality, mood, and psychiatric symptoms among anabolic steroid users. Am J Addict. 1992;1:315-324.
12. Burnett KF, Kleiman ME. Psychological characteristics of adolescent steroid users. Adolescence. 1994;29:81-89.
13. Malone DA Jr, Dimeff R, Lombardo JA, Sample BRH. Psychiatric effects and psychoactive substance use in anabolic-androgenic steroid users. Clin J Sports Med. 1995;5:25-31.
14. Kashkin KB, Kleber HD. Hooked on hormones? an anabolic steroid addiction hypothesis. JAMA. 1989;262:3166-3170.
15. Brower KJ, Blow FC, Young JP, Hill EM. Symptoms and correlates of anabolic-androgenic steroid dependence. Br J Addict. 1991;86:759-768.
16. Conacher GN, Workman DG. Violent crime possibly associated with anabolic steroid use [letter]. Am J Psychiatry. 1989;146:679.
17. Bidwell M, Katz DL. Injecting new life into an old defense: anabolic steroid-induced psychosis as a paradigm of involuntary intoxication. Univ Miami Entertainment Sports Law Rev. 1989;7:1-63.
18. Pope HG Jr, Katz DL. Homicide and near-homicide by anabolic steroid users. J Clin Psychiatry. 1990;51:28-31.
19. Dalby JT. Brief anabolic steroid use and sustained behavioral reaction. Am J Psychiatry. 1990;149:271-272.
20. Stanley A. Anabolic steroids - the drugs that give and take away manhood: case with an unusual physical sign. Med Sci Law. 1994;34:82-83.
21. Choi PYL, Pope HG Jr. Violence toward women and illicit androgenic-anabolic steroid use. Ann Clin Psychiatry. 1994;6:21-25.
22. Pope HG Jr, Kouri EM, Powell KF, Campbell C, Katz DL. Anabolic-androgenic steroid use among 133 prisoners. Compr Psychiatry. 1996;37:322-327.
23. Bahrke MS, Wright JE, Strauss RH, Catlin DH. Psychological moods and subjectively perceived behavioral and somatic changes accompanying anabolic-androgenic steroid use. Am J Sports Med. 1992;20:717-724.
24. Bahrke MS, Yesalis CE. Weight training: a potential confounding factor in examining the psychological and behavioral effects of anabolic-androgenic steroids. Sports Med. 1994;18:309-318.
25. Riem KE, Hursey KG. Using anabolic-androgenic steroids to enhance physique and performance: effects on moods and behavior. Clin Psychol Rev. 1995;15: 235-256.
26. Rubinow DR, Schmidt PJ. Androgens, brain, and behavior. Am J Psychiatry. 1996; 153:974-984.
27. Bagatell CJ, Heiman JR, Matsumoto AM, Rivier JE, Bremner WJ. Metabolic and behavioral effects of high-dose, exogenous testosterone in healthy men. J Clin Endocrinol Metab. 1994;79:561-567.
28. Anderson RA, Bancroft J, Wu FCW. The effects of exogenous testosterone on sexuality and mood of normal men. J Clin Endocrinol Metab. 1992;75:1503-1507.
29. Hannan CJ, Friedl KE, Zold A, Kettler TM, Plymate SR. Psychological and serum homovanillic acid changes in men administered androgenic steroids. Psychoneuroendocrinology. 1991;16:335-343.
30. Forbes GB, Porta CR, Herr BE, Griggs RC. Sequence of changes in body composition induced by testosterone and reversal of changes after drug is stopped. JAMA. 1992;267:397-399.
31. Björkvist K, Nygren T, Björklund AC, Björkvist SE. Testosterone intake and aggressiveness: real effect or anticipation? Aggr Behav. 1994;20:17-26.
32. Griggs RC, Pandya S, Florence JM, et al. Randomized controlled trial of testosterone in myotonic dystrophy. Neurology. 1989;39:219-222.
33. Skakkebaek NE, Bancroft J. Davidson DW, Warner PM. Androgen replacement with oral testosterone undecanoate in hypogonadal men: a double-blind controlled study. Clin Endocrinol. 1981;14:49-61.
34. O'Carroll R, Bancroft J. Testosterone therapy for low sexual interest and erectile dysfunction in men: a controlled study. Br J Psychiatry. 1984;145:146-151.
35. Su T-P, Pagliaro M, Schmidt PJ, Pickar D, Wolkowitz OM, Rubinow DR. Neuropsychiatric effects of anabolic steroids in male normal volunteers. JAMA. 1993; 269:2760-2764.
36. Yates WR, Perry P, Macindoe J, Holman T, Ellingrad V. Psychosexual effects of three doses of testosterone cycling in normal men. Biol Psychiatry. 1999;45: 254-260.
37. Bhasin S, Storer TW, Berman N, et al. The effect of supraphysiologic doses of testosterone on muscle size and strength in normal men. N Engl J Med. 1996; 335:1-7.
38. Tricker R, Casaburi R, Storer TW, et al. The effect of supraphysiological doses of testosterone on angry behavior in healthy eugonadal men. J Clin Endocrinol Metab. 1996;81:3754-3758.
39. Spitzer RL, Williams JBW, Gibbon M. Structured Clinical Interview for DSM-III-R (SCID). New York, NY: New York State Psychiatric Institute; 1989.
40. Jackson AS, Pollock ML. Generalized equations for predicting body density of man. Br J Nutr. 1978;40:497-504.
41. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Revised Third Edition. Washington, DC: American Psychiatric Association; 1987.
42. Young RC, Biggs JT, Ziegler VE, Meyer DA. A rating scale for mania: reliability, validity, and sensitivity. Br J Psychiatry. 1978;133:429-435.
43. Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatry. 1960; 23:56-62.
44. Buss AH, Perry M. The Aggression Questionnaire. J Pers Soc Psychol. 1992;63: 452-459.
45. Derogatis LR. Symptom Checklist-90-R: Administration, Scoring, and Procedures Manual. Minneapolis, Minn: National Computer Systems Inc; 1994.
46. Catlin DH, Kammerer RC, Hatton CK, Sekera MH, Merdink JM. Analytical chemistry at the Games of the XXIIIrd Olympiad in Los Angeles, 1984. Clin Chem. 1987; 33:319-327.
47. Aguilera R, Becchi M, Casablanca H, et al. Improved method of detection of testosterone abuse by gas chromatography/combusion/isotope ratio mass spectrometry analysis of urinary steroids. J Mass Spectrom. 1996;31:169-176.
48. Cherek DR, Schnapp W, Moeller FG, Doughterty DM. Laboratory measures of aggressive responding in male parolees with violent and nonviolent histories. Aggr Behav. 1996;22:27-36.
49. Kouri EM, Lukas SE. Pope HG Jr, Oliva PS. Increased aggressive responding in male volunteers following the administration of gradually increasing doses of testosterone cypionate [published correction appears in Drug Alcohol Depend. 1998;50:255]. Drug Alcohol Depend. 1995;40:73-79.
50. Senn S. The AB/BA crossover: past, present and future? Stat Methods Med Res. 1994;3:303-324.
51. Freeman PR. The performance of the two-stage analysis of two-treatment, two-period crossover trials. Stat Med. 1989;8:1421-1432.
52. Schulte-Beerbuhl M, Nieschlag E. Comparison of testosterone, dihydrotestosterone, luteinizing hormone, and follicle-stimulating hormone in serum after ingestion of testosterone enanthate or testosterone cypionate. Fertil Steril. 1980; 33:201-203.
53. Nankin HR. Hormone kinetics after intramuscular testosterone cypionate. Fertil Steril. 1987:47:1004-1009.
54. SAS Institute Inc. SAS/GIS Software [computer program]: release 6.12. Gary, NC:SAS Institute Inc; 1997.
55. Kouri EM, Pope HG Jr, Katz DL, Oliva PS. Fat-free mass index in users and non-users of anabolic-androgenic steroids. Clin J Sports Med. 1995:5:223-228.
56. Kouri EM, Pope HG Jr, Oliva PS. Changes in lipoprotein-lipid levels in normal men following increasing doses of testosterone cypionate. Clin J Sports Med. 1996;6:152-157.
57. Allen TJ, Dougherty DM, Rhoades HM, Cherek DR. A study of male and female aggressive responding under conditions providing an escape response. Psychol Rec. 1996;46:651-664.